[go: up one dir, main page]

AR056566A1 - Vacunas y procedimientos para tratar la gripe canina - Google Patents

Vacunas y procedimientos para tratar la gripe canina

Info

Publication number
AR056566A1
AR056566A1 ARP060104390A ARP060104390A AR056566A1 AR 056566 A1 AR056566 A1 AR 056566A1 AR P060104390 A ARP060104390 A AR P060104390A AR P060104390 A ARP060104390 A AR P060104390A AR 056566 A1 AR056566 A1 AR 056566A1
Authority
AR
Argentina
Prior art keywords
dogs
viruses
refers
canine
influenza
Prior art date
Application number
ARP060104390A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR056566A1 publication Critical patent/AR056566A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/828—Bacterial vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente se refiere a proporcionar vacunas y tratamientos para las enfermedades relacionadas con virus de la gripe canina. Describe antígenos virales de gripe, y procedimientos para presentar estos antígenos a canes, especialmente perros. se refiere a vacunas muertas y atenuadas. La presente se refiere a virus de la gripo canina y equina generados experimentalmente. También incluye gripe A, incluyendo H3, N8, H3N8, H7N7 y virus que contienen al menos un segmento del genoma de virus de la gripe canina o equina. La presente también se refiere al uso de estos virus en composiciones terapéuticas para proteger canes, perros en particular, de enfermedades causadas por virus de la gripe. Reivindicacion 1: Un procedimiento para inmunizar perros contra virus de la gripe, comprendiendo el procedimiento administrar a un perro una cantidad terapéuticamente eficaz de una vacuna que contiene al menos un virus de la gripe atenuado o muerto.
ARP060104390A 2005-10-07 2006-10-05 Vacunas y procedimientos para tratar la gripe canina AR056566A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72482705P 2005-10-07 2005-10-07

Publications (1)

Publication Number Publication Date
AR056566A1 true AR056566A1 (es) 2007-10-10

Family

ID=37684915

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104390A AR056566A1 (es) 2005-10-07 2006-10-05 Vacunas y procedimientos para tratar la gripe canina

Country Status (18)

Country Link
US (2) US7722884B2 (es)
EP (2) EP2452693A3 (es)
JP (2) JP4667507B2 (es)
KR (2) KR20110126726A (es)
CN (1) CN101309701A (es)
AR (1) AR056566A1 (es)
AU (1) AU2006300927B2 (es)
BR (1) BRPI0616328A2 (es)
CA (1) CA2621320C (es)
ME (1) ME00485B (es)
NO (1) NO20082003L (es)
NZ (1) NZ566490A (es)
PH (1) PH12011502633A1 (es)
RS (1) RS20080138A (es)
RU (1) RU2396976C2 (es)
TW (1) TW200730188A (es)
WO (1) WO2007042884A1 (es)
ZA (1) ZA200802892B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
CN103451158B (zh) * 2005-04-21 2018-11-23 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US7674469B2 (en) * 2006-10-25 2010-03-09 Internet International B.V. Feline influenza vaccine and method of use
EP3300743B1 (en) 2006-12-27 2023-06-14 Zoetis Services LLC Methods of vaccine administration
GB0705245D0 (en) * 2007-03-19 2007-04-25 Stabilitech Ltd Stable biological products
CN101801410A (zh) * 2007-09-10 2010-08-11 英特威国际有限公司 预防犬、猫和马流感传染的组合物和方法
KR100850545B1 (ko) * 2007-10-30 2008-08-05 주식회사 에니멀제네틱스 신규한 개 인플루엔자 바이러스 및 이의 백신
CN104758929B (zh) * 2008-06-27 2018-05-25 硕腾有限责任公司 新颖的佐剂组合物
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
WO2011112593A1 (en) 2010-03-10 2011-09-15 Intervet International B.V. Method for protecting against disease caused by secondary pathogens
CN101892200B (zh) * 2010-03-18 2012-05-30 中国农业科学院哈尔滨兽医研究所 抗h3n8亚型马流感病毒单克隆抗体及其用途
CN103261214B (zh) * 2010-12-22 2016-10-26 英特维特国际股份有限公司 具有活细菌分离物的用于全身施用的疫苗
EP2670432B1 (en) * 2011-02-04 2021-03-17 Zoetis Services LLC Immunogenic bordetella bronchiseptica compositions
CN103596588B (zh) * 2011-02-04 2016-02-03 佐蒂斯有限责任公司 用于犬呼吸道疾病综合征的组合物
BR122019023542B1 (pt) 2011-03-14 2022-02-15 Boehringer Ingelheim Vetmedica, Inc Composição imunogênica compreendendo uma ou mais cepas de vírus da rinite equina b (erbv) inativado e seu método de preparação
EP2704740B1 (en) 2011-05-04 2016-10-05 Streck, Inc. Inactivated swine flu virus and methods of preparing it
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
WO2016083287A1 (en) 2014-11-24 2016-06-02 Intervet International B.V. Inactivated equine influenza virus vaccines
WO2017031408A1 (en) * 2015-08-20 2017-02-23 University Of Rochester Single-cycle virus for the development of canine influenza vaccines
US10973903B2 (en) 2015-08-20 2021-04-13 University Of Rochester NS1 truncated virus for the development of canine influenza vaccines
US10478489B2 (en) 2015-08-20 2019-11-19 University Of Rochester Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
CN105999257A (zh) * 2016-05-11 2016-10-12 长春海基亚生物技术股份有限公司 无针注射流感疫苗系统与应用
US10857224B2 (en) 2016-06-03 2020-12-08 University Of Rochester Equine influenza virus live attenuated vaccines
WO2019168911A1 (en) 2018-02-27 2019-09-06 University Of Rochester Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (eiv) in horses

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
EP0231039B1 (en) 1986-01-14 1992-01-08 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Process for preparing immunological complexes and pharmaceutical composition containing these complexes
DE69838992T2 (de) * 1997-09-05 2008-12-24 Glaxosmithkline Biologicals S.A., Rixensart Öl-in-Wasser Emulsionen mit Saponinen
US6051239A (en) 1997-10-20 2000-04-18 Thomas Jefferson University Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
US6482414B1 (en) 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) * 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
US7629440B2 (en) 2002-08-20 2009-12-08 Genitrix, Llc Lectin compositions and methods for modulating an immune response to an antigen
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
US7572620B2 (en) 2005-01-11 2009-08-11 Wisconsin Alumni Research Foundation H3 equine influenza A virus
US8137676B2 (en) 2005-02-15 2012-03-20 Mount Sinai School Of Medicine Genetically engineered equine influenza virus and uses thereof
CN101193655A (zh) * 2005-04-11 2008-06-04 美国政府健康及人类服务部，疾病控制和预防中心 抗大流行性流感病毒株的疫苗
CN103451158B (zh) * 2005-04-21 2018-11-23 佛罗里达大学研究基金公司 用于犬科动物中呼吸系统疾病控制的物质和方法
WO2007012033A2 (en) 2005-07-20 2007-01-25 Zymogenetics, Inc. Il28 and il29 truncated cysteine mutants and antiviral methods of using same
GB0517293D0 (en) 2005-08-24 2005-10-05 Cancer Rec Tech Ltd Vectors and uses thereof
US7384642B2 (en) 2005-08-25 2008-06-10 Merial Limited Canine influenza vaccines
US7425336B2 (en) 2005-08-25 2008-09-16 Mevial Limited Canine influenza vaccines
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
WO2007047728A2 (en) 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease

Also Published As

Publication number Publication date
KR20110126726A (ko) 2011-11-23
RS20080138A (sr) 2009-07-15
RU2008113207A (ru) 2009-10-10
WO2007042884A9 (en) 2008-05-29
AU2006300927B2 (en) 2010-05-13
EP2452693A3 (en) 2012-06-06
JP2009511464A (ja) 2009-03-19
CA2621320A1 (en) 2007-04-19
US7722884B2 (en) 2010-05-25
BRPI0616328A2 (pt) 2011-06-14
CN101309701A (zh) 2008-11-19
PH12011502633A1 (en) 2012-11-12
EP1945254A1 (en) 2008-07-23
KR20080042174A (ko) 2008-05-14
EP2452693A2 (en) 2012-05-16
AU2006300927A1 (en) 2007-04-19
TW200730188A (en) 2007-08-16
RU2396976C2 (ru) 2010-08-20
CA2621320C (en) 2016-05-24
JP4667507B2 (ja) 2011-04-13
NZ566490A (en) 2011-06-30
NO20082003L (no) 2008-06-24
ZA200802892B (en) 2009-01-28
JP2009298802A (ja) 2009-12-24
US20070082012A1 (en) 2007-04-12
ME00485B (me) 2011-10-10
US20080254063A1 (en) 2008-10-16
WO2007042884A1 (en) 2007-04-19
US7879336B2 (en) 2011-02-01

Similar Documents

Publication Publication Date Title
AR056566A1 (es) Vacunas y procedimientos para tratar la gripe canina
Hanlon et al. Rabies in terrestrial animals
EA200970013A1 (ru) Вакцинация против гриппа по схеме многократного введения с использованием безадъювантной дозы
MX2019009443A (es) Metodos para tratar la influenza.
CY1120015T1 (el) Μεθοδοι χορηγησης εμβολιων
ATE547118T1 (de) Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung
PE20151588A1 (es) Vacuna contra el virus del dengue
ATE554789T1 (de) Neues hundeinfluenza-virus und imfpstoff hierfür
CL2008000445A1 (es) Metodo para la profilaxis y el tratamiento de una infeccion subclinica por circovirus porcino tipo 2 (pcv2) en un animal individual o un grupo de animales que comprende administrar un antigeno del pcv2; uso del antigeno pcv2 para la profilaxis de un
UY32717A (es) Inhibidores de la replicación de virus de la gripe
MX2019005137A (es) Vacuna contra parvovirus porcino.
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
CL2019000722A1 (es) Nueva vacuna contra la gripe porcina.
CL2013002219A1 (es) Composicion inmunogena que comprende bordetella bronchiseptica y un antigeno de pertactina aislado; y su uso para tratar o prevenir la infeccion por un patogeno respiratorio canino en un perro.
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
CO2020009043A2 (es) Anticuerpos humanos contra hemaglutinina de influenza
AR108829A1 (es) Vacuna contra virus de bronquitis infecciosa
BR112014003278A2 (pt) vacinas para influenza h5
AR056712A1 (es) Composicion y vacuna efectiva para tratar prevenir o mejorar la inoculacion del virus de la influenza canina metodo pra generar un inmunogen del virus dela influenza equina o del virus de la influenza canina modelo de la inoculacion util para determinar la eficacia de la composicion contra el virus
AR031032A1 (es) Uso de la tolterodina en el tratamiento del asma
EA201500770A1 (ru) Поливалентная вакцина против гриппа на основе гибридного белка
MX2021005257A (es) Composicion inmunogenica contra el subtipo h5 del virus de la influenza aviar.
MX2021006654A (es) Uso de extracto de cocculus hirsutus para tratar dengue.
BR112013019850A8 (pt) Composições de vacina e seu uso no tratamento ou prevenção de doenças respiratórias infecciosas caninas
CO2022005281A2 (es) Anticuerpos antihemaglutinina y métodos de uso de estos

Legal Events

Date Code Title Description
FB Suspension of granting procedure